Wilson Sonsini Goodrich & Rosati advised Seal Rock on the transaction. Seal Rock Therapeutics, Inc., a clinical stage company developing first-in-class and best-in-class kinase inhibitors, has...
Seal Rock Therapeutics’ Out-Licensing Agreement with GENFIT
Equillium’s Acquisition of Metacrine
Wilson Sonsini advised Metacrine on the deal. Equillium, Inc. and Metacrine Inc. announced that the two companies have entered into a definitive merger agreement pursuant to...